/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Fennec Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$7.56 -0.0053(-0.53%) FENC at 04 Dec 2025 04:31 PM Biotechnology
Lowest Today 7.46
Highest Today 7.705
Today’s Open 7.46
Prev. Close 7.61
52 Week High 9.92
52 Week Low 4.68
Day’s Range: Low 7.46 High 7.705
52-Week Range: Low 4.68 High 9.92
1 day return -
1 Week return -7.71
1 month return -5.98
3 month return -17.77
6 month return -2.07
1 year return +23.6
3 year return -21.29
5 year return -6.56
10 year return -

Institutional Holdings

Southpoint Capital Advisors LP 14.65

Solas Capital Management LLC 8.02

Rosalind Advisors, Inc. 7.35

BlackRock Inc 4.41

Vanguard Group Inc 3.47

Vanguard Total Stock Mkt Idx Inv 2.79

iShares Russell 2000 ETF 1.94

AIGH Capital Management, LLC 1.63

State Street Corp 1.21

Geode Capital Management, LLC 1.09

Harbert Fund Advisors Inc 1.03

Morgan Stanley - Brokerage Accounts 0.91

Fidelity Small Cap Index 0.84

Lion Point Capital, LP 0.70

iShares Russell 2000 Value ETF 0.54

Gendell Jeffrey L 0.50

Northern Trust Corp 0.47

Vanguard Russell 2000 ETF 0.40

The Informed Momentum Company (formerly EAM Investors) 0.28

State St Russell Sm Cap® Indx SL Cl I 0.25

Charles Schwab Investment Management Inc 0.22

Schwab Small Cap Index 0.22

NT R2000 Index Fund - NL 0.21

IMC US Ultra Micro Cap 0.20

iShares Russell 2000 Growth ETF 0.19

iShares Micro-Cap ETF 0.19

Bank of New York Mellon Corp 0.19

Hartford Financial Management Inc. 0.18

Jane Street Group LLC 0.18

Susquehanna International Group, LLP 0.17

Citadel Advisors Llc 0.17

NT R2000 Index Fund - DC - NL - 3 0.16

Pleiades Small Cap Equity A 0.15

Russell 2500™ Index Fund F 0.15

iShares Russell 2000 Small-Cap Idx Instl 0.14

Russell 2000 Index Non-Lendable Fund E 0.11

SPDR® Russell 2000 US Small Cap ETF 0.10

EQ/2000 Managed Volatility IB 0.10

Nuveen Small Cap Blend Idx R6 0.09

Bridgeway Ultra-Small Company 0.09

Market Status

Strong Buy: 3

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 259.91 M

PB Ratio 57.9258

PE Ratio 0.0

Enterprise Value 270.49 M

Total Assets 44.95 M

Volume 155185

Company Financials

Annual Revenue FY23:13052000 13.1M, FY22:1535000 1.5M, FY21:0 0.0M, FY20:170000 0.2M, FY19:0 0.0M

Annual Profit FY23:12392000 12.4M, FY22:1449000 1.4M, FY21:null 0.0M, FY20:170000 0.2M, FY19:null 0.0M

Annual Net worth FY23:-20220000 -20.2M, FY22:-24839000 -24.8M, FY21:-17456000 -17.5M, FY20:-17922000 -17.9M, FY19:-12460000 -12.5M

Quarterly Revenue Q3/2025:12462000 12.5M, Q2/2025:9652000 9.7M, Q1/2025:8751000 8.8M, Q3/2024:6974000 7.0M, Q2/2024:7262000 7.3M

Quarterly Profit Q3/2025:11802000 11.8M, Q2/2025:8685000 8.7M, Q1/2025:8378000 8.4M, Q3/2024:5617000 5.6M, Q2/2024:6654000 6.7M

Quarterly Net worth Q3/2025:-638000 -0.6M, Q2/2025:-3152000 -3.2M, Q1/2025:-1165000 -1.2M, Q3/2024:-5735000 -5.7M, Q2/2024:-5553000 -5.6M

Fund house & investment objective

Company Information Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Organisation Biotechnology

Employees 32

Industry Biotechnology

CEO Mr. Jeffrey S. Hackman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow